NCT02348879View on ClinicalTrials.gov

A Study to Examine the Safety, Pharmacokinetics and Pharmacodynamics of AMG 403 in Healthy Subject

PHASE1CompletedINTERVENTIONAL
Enrollment

51

Participants

Timeline

Start Date

January 31, 2005

Primary Completion Date

January 31, 2006

Study Completion Date

March 31, 2006

Conditions
Chronic Pain
Interventions
DRUG

AMG 403

AMG 403 is for treatment of subjects with chronic pain

DRUG

Placebo

contains no active drug

Sponsors

Lead Sponsor

Amgen
All Listed Sponsors
lead

Amgen

INDUSTRY